X

About this post

Source
Author
Date
5:00 AM | February 15, 2013
Language
English
Categories
URL
Link to this page


Elcelyx Therapeutics has secured $20 million in Series C financing to fund clinical trials of its Lovidia over-the-counter weight loss product, and NewMet for Type 2 diabetes.

Tags

+ Add Tag

Comments

Log in to leave a comment